russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2023-5717ERCEOArussjcardiol-5717Research ArticleНАБЛЮДАТЕЛЬНЫЕ ИССЛЕДОВАНИЯОбоснование проведения имплементационного исследования по внедрению клинических рекомендаций по нарушениям липидного обмена в рутинную практикуRationale for implementation study to introduce clinical guidelines on lipid metabolism disorders into routine practicehttps://orcid.org/0000-0002-0108-5996УсоваЕ. И.UsovaE. I.

Врач-кардиолог, м.н.с. НИЛ нарушений липидного обмена и атеросклероза НЦМУ "Центр персонализированной медицины"

Санкт-Петербург

St. Petersburg

el.lenkin@yandex.ruhttps://orcid.org/0000-0002-9845-331XАлиеваА. С.AlievaA. S.

К.м.н., врач-кардиолог, зав. НИЛ нарушений липидного обмена и атеросклероза НЦМУ "Центр персонализированной медицины", руководитель Центра Атеросклероза и нарушений липидного обмена

Санкт-Петербург

St. Petersburg

asiiat.alieva.s@gmail.comhttps://orcid.org/0000-0001-6533-5950ЗвартауН. Э.ZvartauN. E.

К.м.н., доцент, зам. генерального директора по работе с регионами, доцент кафедры факультетской терапии лечебного факультета Института медицинского образования

Санкт-Петербург

St. Petersburg

n.e.zvartau@yandex.ruhttps://orcid.org/0000-0003-2929-0980ШляхтоЕ. В.ShlyakhtoE. V.

Д.м.н., профессор, академик РАН, заслуженный деятель науки Российской Федерации, Президент Российского кардиологического общества, главный внештатный специалист-кардиолог СЗФО, ЮФО, СКФО, ПФО, главный внештатный специалист-кардиолог Комитета по здравоохранению Правительства Санкт-Петербурга, генеральный директор

Санкт-Петербург

St. Petersburg

shlyakhto_ev@almazovcentre.ruФГБУ Национальный медицинский исследовательский центр им. В.А. Алмазова Минздрава РоссииРоссияAlmazov National Medical Research CenterRussian Federation202320122023281257175717Copyright © Усова Е.И., Алиева А.С., Звартау Н.Э., Шляхто Е.В., 20232023Усова Е.И., Алиева А.С., Звартау Н.Э., Шляхто Е.В.Usova E.I., Alieva A.S., Zvartau N.E., Shlyakhto E.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/5717

Опубликованные исследования демонстрируют недостаточную степень внедрения клинических рекомендаций в реальную клиническую практику. Успех применения основных принципов диагностики и лечения пациентов с нарушениями липидного обмена напрямую зависит от идентификации барьеров и использования стратегий для их преодоления, что является областью интересов имплементационной науки. Приводится обоснование запланированной дистанционной трехуровневой оценки действующей системы оказания медицинской помощи пациентам с дислипидемией (анкетирование с использованием уровень-специфичных структурированных опросников для практикующих врачей, руководителей медицинских организаций и главных внештатных специалистов) для выявления ключевых барьеров, стоящих на пути внедрения и соблюдения клинических рекомендаций. Данные, полученные в рамках использования ключевых подходов имплементационной науки, позволят сформировать стратегии, направленные на улучшение соблюдения рекомендаций по ведению пациентов с нарушениями липидного обмена в реальной клинической практике.

Published studies demonstrate insufficient implementation of clinical guidelines into actual clinical practice. Successful implementation of diagnostic and treatment guidelines for patients with lipid metabolism disorders directly depends on the identification of barriers and timely application of strategies to overcome them. A three-level remote structural questionary of healthcare quality for patients with dyslipidemia involved practitioner, heads of outpatient medical organizations and chief outpatient specialists to identify key barriers to implementation and compliance with clinical guidelines in real world setting. The obtained data in combination with implementation science approaches will facilitate development of strategies aimed to improvement of compliance with the guidelines for the management of patients with lipid metabolism disorders in practice.

липидологияклинические рекомендацииреальная клиническая практикаанкетированиеимплементационная наукаlipidologyclinical guidelinesclinical practicequestionnairesimplementation scienceИсследование проведено при поддержке ООО "Новартис Фарма"The study was supported by Novartis Pharma LLC.ReferencesMach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111-88. doi:10.1093/eurheartj/ehz455.Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111-88. doi:10.1093/eurheartj/ehz455.Ежов М. В., Кухарчук В. В., Сергиенко И. В. и др. Нарушения липидного обмена. Клинические рекомендации 2023. Российский кардиологический журнал. 2023;28(5):5471. doi:10.15829/1560-4071-2023-5471.Ezhov MV, Kukharchuk VV, Sergienko IV, et al. Disorders of lipid metabolism. Clinical Guidelines 2023. Russian Journal of Cardiology. 2023;28(5):5471. (In Russ.) doi:10.15829/1560-4071-2023-5471.Ray KK, Haq I, Bilitou A, et al. Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe — Methodology and rationale for the multinational observational SANTORINI study. Atheroscler Plus. 2021;43:24-30. doi:10.1016/j.athplu.2021.08.003.Ray KK, Haq I, Bilitou A, et al. Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe — Methodology and rationale for the multinational observational SANTORINI study. Atheroscler Plus. 2021;43:24-30. doi:10.1016/j.athplu.2021.08.003.Марцевич С.Ю., Лукина Ю.В., Кутишенко Н.П. и др. Проблемные вопросы терапии статинами в клинической практике (по данным амбулаторного регистра ПРОФИЛЬ). Рациональная Фармакотерапия в Кардиологии. 2022;18(1):73-8. doi:10.20996/1819-6446-2022-02-02.Martsevich SYu, Lukina YuV, Kutishenko NP, et al. Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register "PROFILE" Data). Rational Pharmacotherapy in Cardiology. 2022;18(1):73-8. (In Russ.) doi:10.20996/1819-6446-2022-02-02.Ray KK, Molemans B, Schoonen WM. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. European Journal of Preventive Cardiology. 2020;zwaa047. doi:10.1093/eurjpc/zwaa047.Ray KK, Molemans B, Schoonen WM. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. European Journal of Preventive Cardiology. 2020;zwaa047. doi:10.1093/eurjpc/zwaa047.Оганов Р.Г., Кухарчук В.В., Арутюнов Г.П. и др. Сохраняющиеся нарушения показателей липидного спектра у пациентов с дислипидемией, получающих статины, в реальной клинической практике в Российской Федерации (российская часть исследования DYSIS). Кардиоваскулярная терапия и профилактика. 2012;11(4):70-8. doi:10.15829/1728-8800-2012-4-70-78.Oganov RG, Kukharchuk VV, Arutyunov GP, et al. Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study). Cardiovascular Therapy and Prevention. 2012;11(4):70-8. (In Russ.) doi:10.15829/1728-8800-2012-4-70-78.Galaviz KI, Barnes GD. Implementation Science Opportunities in Cardiovascular Medicine. Circ Cardiovasc Qual Outcomes. 2021;14(7):e008109. doi:10.1161/CIRCOUTCOMES.121.008109.Galaviz KI, Barnes GD. Implementation Science Opportunities in Cardiovascular Medicine. Circ Cardiovasc Qual Outcomes. 2021;14(7):e008109. doi:10.1161/CIRCOUTCOMES.121.008109.Eccles MP, Mittman BS. Welcome to Implementation Science. Implementation Sci 1. 1 (2006). doi:10.1186/1748-5908-1-1Eccles MP, Mittman BS. Welcome to Implementation Science. Implementation Sci 1. 1 (2006). doi:10.1186/1748-5908-1-1Fischer F, Lange K, Klose K, et al. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016;4(3):36. doi:10.3390/healthcare4030036.Fischer F, Lange K, Klose K, et al. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016;4(3):36. doi:10.3390/healthcare4030036.Balas EA, Boren SA. Managing Clinical Knowledge for Health Care Improvement. Yearb Med Inform. 2000;(1):65-70.Balas EA, Boren SA. Managing Clinical Knowledge for Health Care Improvement. Yearb Med Inform. 2000;(1):65-70.Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi:10.1186/1748-5908-4-50.Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi:10.1186/1748-5908-4-50.Atkins L, Francis J, Islam R, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. doi:10.1186/s13012-017-0605-9.Atkins L, Francis J, Islam R, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. doi:10.1186/s13012-017-0605-9.Birken SA, Powell BJ, Presseau J, et al. Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review. Implement Sci. 2017;12(1):2. doi:10.1186/s13012-016-0534-z.Birken SA, Powell BJ, Presseau J, et al. Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review. Implement Sci. 2017;12(1):2. doi:10.1186/s13012-016-0534-z.Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:21. doi:10.1186/s13012-015-0209-1.Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:21. doi:10.1186/s13012-015-0209-1.Mowatt G, Grimshaw JM, Davis DA, Mazmanian PE. Getting evidence into practice: the work of the Cochrane Effective Practice and Organization of care Group (EPOC). J Contin Educ Health Prof. 2001;21(1):55-60. doi:10.1002/chp.1340210109.Mowatt G, Grimshaw JM, Davis DA, Mazmanian PE. Getting evidence into practice: the work of the Cochrane Effective Practice and Organization of care Group (EPOC). J Contin Educ Health Prof. 2001;21(1):55-60. doi:10.1002/chp.1340210109.Waltz TJ, Powell BJ, Matthieu MM, et al. Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study. Implement Sci. 2015;10:109. doi:10.1186/s13012-015-0295-0.Waltz TJ, Powell BJ, Matthieu MM, et al. Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study. Implement Sci. 2015;10:109. doi:10.1186/s13012-015-0295-0.Sposito AC, Ramires JA, Jukema JW, et al. Physicians’ attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. Curr Med Res Opin. 2009;25(5):1171-8. doi:10.1185/03007990902846423.Sposito AC, Ramires JA, Jukema JW, et al. Physicians’ attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. Curr Med Res Opin. 2009;25(5):1171-8. doi:10.1185/03007990902846423.Jones LK, Sturm AC, Seaton TL, et al. Barriers, facilitators, and solutions to familial hypercholesterolemia treatment. PLoS One. 2020;15(12):e0244193. doi:10.1371/journal.pone.0244193.Jones LK, Sturm AC, Seaton TL, et al. Barriers, facilitators, and solutions to familial hypercholesterolemia treatment. PLoS One. 2020;15(12):e0244193. doi:10.1371/journal.pone.0244193.Koskinas KC, Catapano AL, Baigent C, et al. Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey. Eur J Prev Cardiol. 2022;28(18):2030-7. doi:10.1093/eurjpc/zwaa156.Koskinas KC, Catapano AL, Baigent C, et al. Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey. Eur J Prev Cardiol. 2022;28(18):2030-7. doi:10.1093/eurjpc/zwaa156.Cannon CP, de Lemos JA, Rosenson RS, et al. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US [published online ahead of print, 2021 Jun 16]. JAMA Cardiol. 2021;e211810. doi:10.1001/jamacardio.2021.1810.Cannon CP, de Lemos JA, Rosenson RS, et al. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US [published online ahead of print, 2021 Jun 16]. JAMA Cardiol. 2021;e211810. doi:10.1001/jamacardio.2021.1810.Bytyçi I, Penson PE, Mikhailidis DP, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213-23. doi:10.1093/eurheartj/ehac015.Bytyçi I, Penson PE, Mikhailidis DP, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213-23. doi:10.1093/eurheartj/ehac015.Nelson AJ, Haynes K, Shambhu S, et al. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S. J Am Coll Cardiol. 2022;79(18):1802-13. doi:10.1016/j.jacc.2022.02.048.Nelson AJ, Haynes K, Shambhu S, et al. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S. J Am Coll Cardiol. 2022;79(18):1802-13. doi:10.1016/j.jacc.2022.02.048.Uchmanowicz I, Hoes A, Perk J, et al. Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed? Eur J Prev Cardiol. 2020:2047487320926776. doi:10.1177/2047487320926776.Uchmanowicz I, Hoes A, Perk J, et al. Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed? Eur J Prev Cardiol. 2020:2047487320926776. doi:10.1177/2047487320926776.Song Y, Ballesteros M, Li J, et al. Current practices and challenges in adaptation of clinical guidelines: a qualitative study based on semistructured interviews. BMJ Open. 2021;11(12):e053587. doi:10.1136/bmjopen-2021-053587.Song Y, Ballesteros M, Li J, et al. Current practices and challenges in adaptation of clinical guidelines: a qualitative study based on semistructured interviews. BMJ Open. 2021;11(12):e053587. doi:10.1136/bmjopen-2021-053587.Grol R, Grimshaw J.From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225-30. doi:10.1016/S0140-6736(03)14546-1.Grol R, Grimshaw J.From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225-30. doi:10.1016/S0140-6736(03)14546-1.Lugtenberg M, Zegers-van Schaick JM, Westert GP, Burgers JS. Why don’t physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci. 2009;4:54. doi:10.1186/1748-5908-4-54.Lugtenberg M, Zegers-van Schaick JM, Westert GP, Burgers JS. Why don’t physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci. 2009;4:54. doi:10.1186/1748-5908-4-54.Gagliardi AR, Alhabib S; members of Guidelines International Network Implementation Working Group. Trends in guideline implementation: a scoping systematic review. Implement Sci. 2015;10:54. doi:10.1186/s13012-015-0247-8.Gagliardi AR, Alhabib S; members of Guidelines International Network Implementation Working Group. Trends in guideline implementation: a scoping systematic review. Implement Sci. 2015;10:54. doi:10.1186/s13012-015-0247-8.Jones LK, Sturm AC, Gionfriddo MR. Translating guidelines into practice via implementation science: an update in lipidology. Curr Opin Lipidol. 2022;33(6):336-41. doi:10.1097/MOL.0000000000000835.Jones LK, Sturm AC, Gionfriddo MR. Translating guidelines into practice via implementation science: an update in lipidology. Curr Opin Lipidol. 2022;33(6):336-41. doi:10.1097/MOL.0000000000000835.

The authors declare that there are no conflicts of interest present.